March 8, 2018 / 1:18 PM / in 7 months

BRIEF-Genomic Health Reports Q4 Earnings Per Share $0.05

March 8 (Reuters) - Genomic Health Inc:

* GENOMIC HEALTH ANNOUNCES 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS, PROVIDES 2018 FINANCIAL OUTLOOK

* SEES 2018 GAAP EPS OF $ 0.16 TO $ 0.22

* GENOMIC HEALTH - ‍WILL NO LONGER PROVIDE ONCOTYPE SEQ LIQUID SELECT TEST OR FURTHER INVEST IN NON-PROPRIETARY NGS-BASED PANELS​

* SEES 2018 NON-GAAP EPS IN RANGE OF $ 0.32 TO $ 0.50

* Q4 EARNINGS PER SHARE VIEW $0.07, REVENUE VIEW $88.9 MILLION — THOMSON REUTERS I/B/E/S

* ‍WILL REDUCE POSITIONS BY ABOUT 10 PERCENT & TAKE A CHARGE OF ABOUT $10 MILLION IN Q1​

* FY2018 EARNINGS PER SHARE VIEW $0.34, REVENUE VIEW $383.8 MILLION — THOMSON REUTERS I/B/E/S

* GENOMIC HEALTH - IN 2018, PLANS TO DIRECT RESOURCES TO EXPAND ITS ONCOTYPE DX OFFERING

* GENOMIC HEALTH - TO NO LONGER PROVIDE ONCOTYPE SEQ LIQUID SELECT TEST/FURTHER INVEST IN NON-PROPRIETARY NEXT-GENERATION SEQUENCING (NGS)-BASED PANELS

* IN CONNECTION TO THE SHIFT IN FOCUS, CO WILL REDUCE POSITIONS BY ABOUT 10 PERCENT

* GENOMIC HEALTH-TO TAKE CHARGE OF ABOUT $10 MILLION IN Q1 FOR COSTS WITH PERSONNEL REDUCTIONS&WRITE-OFF OF CERTAIN ASSETS ASSOCIATED WITH NGS-BASED PANELS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below